This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ryan, M. Articles by Slevin, J. T. Search for Related Content Social Bookmarking                         What's this?

Restless Legs Syndrome

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, maryan1{at}email.uky.edu, Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky

John T. Slevin, MD, MBA

Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic and Neurology Service (127), Veterans Affairs Medical Center, Lexington, Kentucky

Restless legs syndrome is a symptomatic urge to move the legs, usually accompanied or caused by uncomfortable/ unpleasant sensations deep within the legs that begin or are worsened during periods of rest or inactivity in the evening or night and are partially or totally relieved by movement. It can occur intermittently or daily. Nonpharmacologic treatments include moderate exercise; good sleep hygiene; elimination of alcohol, caffeine, and nicotine; and hot baths, massage, and stretching. Activities promoting mental alertness may improve symptoms. Moderate exercise and use of nasal continuous positive airway pressure are the only nonpharmacologic treatments with proven benefit. For intermittent restless legs syndrome, carbidopa/levodopa and nonpharmacologic therapy are recommended as primary treatments. For daily restless legs syndrome, dopamine agonists, particularly ropinirole and pramipexole, are suggested as the drugs of choice. Carbidopa/levodopa could be considered for daily restless legs syndrome, but augmentation is a significant drawback to its use. Carbamazepine and gabapentin have limited data to support their use.

Key Words: Restless legs syndrome • periodic movement disorder of sleep • limb movements.

Journal of Pharmacy Practice, Vol. 20, No. 6, 430-448 (2007)
DOI: 10.1177/0897190007310914


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?